Session 3

  • Location:
    AIDA
  • Chairs:
     A. Bjartell, Malmö (SE)
     K. Junker, Homburg (DE)
Tumour heterogeneity in kidney cancer: Molecular genetic picture
 S. Turajlic, London (GB)
Tumour heterogeneity in kidney cancer: Important for clinical decision?
 A. Volpe, Novara (IT)
Diagnostic challenges of clonal heterogeneity in prostate cancer
 M.C. Haffner, Baltimore (US)
The evolutionary history of lethal metastatic cancer
 C. Cooper, Sutton, Surrey (GB)
Tumour heterogeneity in prostate cancer: Implications for therapy
 M. Stöckle, Homburg (DE)